NVO Tshuag: Kev Muag Khoom Zoo Tshaj Plaws yuav luag ob npaug, Tab sis qhov ntawd tsis txaus rau cov neeg lag luam

Danish kws tsim tshuaj Novo Nordisk (NVO) plam qhov kev cia siab thib ob rau hnub Wednesday tab sis tsa nws qhov kev pom zoo rau xyoo tas los. NVO stock poob lawm.




X



Kev muag khoom nce 25% rau 41.27 lab Danish Kroner - lossis txog $ 5.62 nphom. Kho cov nyiaj tau los ntawm 5.86 Danish Kroner ib feem, nce ntau dua 11%. Qhov ntawd txhais tau li ntawm 80 xees ntawm cov nyiaj tau los hloov kho ib feem hauv US las. Tab sis ob qho tib si kev ntsuas tau tshwm sim, raws li FactSet.

Lub tuam txhab tau tshaj tawm txoj kev loj hlob zoo rau nws txoj kev kho mob ntshav qab zib thiab rog rog, nce 28%. Novo Nordisk tau hais tias nws cov tshuaj ntshav qab zib hauv chav kawm GLP-1 - Rybelsus thiab Ozempic - tsav tus tsov ntxhuav feem ntawm kev loj hlob. Ua ke, kev muag khoom ntawm cov tshuaj no tau nce 57%. Kev muag khoom ntawm kev kho mob rog tau nce 99%.

Tab sis rau hnub no lub khw lag luam, NVO Tshuag poob 12.7% mus rau 99.91.

NVO Tshuag: nce 2022 Kev taw qhia

Novo Nordisk tau ua lub npe rau nws tus kheej hauv ntshav qab zib. Nws yog tam sim no nthuav dav ntxiv rau kev rog rog thiab kev kho rog rog, qhov twg Eli Lilly (LLY) sai sai vam tias yuav ua rau inroads.

Thaum kawg ntawm lub xyoo, Novo Nordisk hais tias nws npaj yuav ua tag nrho cov tshuaj ntawm nws cov tshuaj poob phaus tshiab, Wegovy, muaj nyob hauv Asmeskas

Rau lub xyoo, Novo Nordisk tau hu rau kev muag khoom kom loj hlob 12% -16% hauv cov txiaj ntsig tas li thiab cov nyiaj tau los nce 11% -15%. Qhov ntawd yog qhov nce ntawm lub tuam txhab cov lus qhia yav dhau los rau 10% -14% thiab 9% -13%, feem.

Tab sis NVO Tshuag poob qis hauv qab nws 50-hnub thiab 200-hnub txav nruab nrab, MarketSmith.com qhia. Shares yog consolidating nrog a muas point ntawm 122.26.

NVO Tshuag kuj tseem muaj zog Puas Ntsuam Xyuas ntawm 92, uas tso cov khoom lag luam hauv thawj 8% ntawm tag nrho cov khoom lag luam nyob rau hauv cov nqe lus ntawm qhov tseem ceeb thiab kev ntsuas.

Ntxiv mus, shares muaj ib tug bullish Ntsuam Xyuas Lub Zog Muaj Zog ntawm 90. Qhov no txhais tau tias NVO cov khoom lag luam ua lag luam nyob rau sab saum toj 10% ntawm tag nrho cov khoom lag luam nyob rau hauv cov nqe lus ntawm 12-lub hlis kev ua tau zoo, raws li IB Digital.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Moderna Tshuag Tshaj Tawm Tom Qab Cov Tshuaj Tiv Thaiv Kev Muag Khoom Obliterate Kev Cia Siab

Alnylam Pharmaceuticals Taug Kev Mus Ntaus Cov Ntaub Ntawv Siab - Ntawm no yog vim li cas

Saib IBD Cov Lus Qhia Txog Kev nqis peev qhia rau Kev Ua Lag Luam Kev Pom Zoo

Koom nrog IBD Ua Neej Rau Cov Lus Qhia Ua Lag Luam Sawv ntxov Ua Ntej Qhib

Pom Qhov Kev Lag Luam Zoo Tshaj Plaws Sij Hawm Zoo Nrog IBD Cov Thawj Coj Ua Haujlwm Ntev

Tau qhov twg los: https://www.investors.com/news/technology/nvo-stock-obesity-sales-nearly-double-but-that-was-not-enough-for-investors/?src=A00220&yptr=yahoo